Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
Aliana Guerrieri-GonzagaDavide SerranoPatrizia GnagnarellaHarriet JohanssonStefania ZovatoMariateresa NardiMatilde PensabeneSimona BuccoloAndrea DeCensiIrene Maria BriataLuigi PistelliClementina SansoneSara MannucciValentina AristarcoDebora MacisMatteo LazzeroniGaetano AurilioChiara Arianna AccorneroSara GandiniBernardo BonanniPublished in: PloS one (2024)
EuCT number:2023-503994-39-00; Clinical trials.gov NCT06033092.
Keyphrases
- phase ii
- clinical trial
- open label
- study protocol
- low dose
- phase iii
- double blind
- placebo controlled
- breast cancer risk
- randomized controlled trial
- polycystic ovary syndrome
- metabolic syndrome
- high dose
- type diabetes
- weight loss
- estrogen receptor
- pregnancy outcomes
- pregnant women
- skeletal muscle
- cervical cancer screening
- positive breast cancer